Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Stone, G. McNab, R. Stockley, E. Sapey (Birmingham, United Kingdom). Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD. Eur Respir J 2011; 38: Suppl. 55, 4033

Member's Comments

No comment yet.

Related content which might interest you: Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency}, Source: Eur Respir J 2012; 40: 561-569 Year: 2012 Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Source: Eur Respir J 2007; 30: 472-478 Year: 2007 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Characteristic of cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Sputum cytokine profiling according to the type of airway inflammation in obstructive pulmonary diseases Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010